Outlook on the Microneedles for Drug Delivery Patent Landscape Global Industry - Featuring Altea, Becton Dickinson and Fujifilm Among Others - ResearchAndMarkets.com

·4-min read

The "Microneedles for Drug Delivery Patent Landscape" report has been added to ResearchAndMarkets.com's offering.

The global drug delivery market has been observed to be as large as USD 440.5 billion in 2018.

Hypodermic needles are known to be very efficient and they have been used immensely in the delivery of biological macromolecules, insulin, vaccines, etc. However, their invasive nature, stability issues, and non-compliance have always been the issues of concern and led to the requirement of highly skilled medical practitioners for administration.

In this context, microneedles have shown immense potential, since they can easily, painlessly and safely deliver drugs without special storage infrastructure. Hence, they can be self-administered by anybody, thereby eliminating the need for a clinic visit and the assistance of skilled medical practitioners. This serves as an important advantage, especially in the emerging markets. Moreover, microneedles do not create sharp waste, thereby eliminating the problem of discarding needles and hazardous risks. Patients suffering from needle phobia can easily use microneedles. Indeed, according to a study published in Behavioral Neurology, 2014, around 3-4% of the world population faces needle phobia.

Microneedles for drug delivery are attracting interest from big companies and start-ups alike and show immense potential that could transform the global transdermal market. Furthermore, in the actual race to find a COVID-19 vaccine, numerous companies (e.g. Kindeva (3M), Debiotech, Verndari, NanoPass, Bioserentach, Sorrento Therapeutics, Merck, etc.) have developed or shared their microneedle delivery system and promising results have already been released. Other fields, like cosmetic, ophthalmic and diabetes showed important technological progress in the past few years that could disrupt the existing market and replace the current standard drug delivery system.

In this evolving context, it is crucial to understand the intellectual property position and strategy of these different players. Such knowledge can help detect business risks and opportunities, anticipate emerging technologies, and enable strategic decisions to strengthen one's market position.

Report's Key Features

  • PDF with > 140 slides

  • Excel file > 2,450 patent families

  • IP trends, including time-evolution of published patents, and countries of patent filings

  • Patents' legal status

  • Ranking of main patent assignees

  • Key players' IP position and relative strength of their patent portfolios

  • Summary of the IP related to applications: Cancer therapy, Cosmetic, Diabetes, Ophthalmic, Pain management and Vaccine.

  • Summary of the IP related to technologies: Applicators, housing, Coated, Hollow, Porous, Soluble, Hydrogel and Solid microneedles.

  • Analysis of patent oppositions (Europe) and review of key patents.

  • Excel database containing all patents analyzed in the report, including applications and technologies segmentations

Key Topics Covered:

1. INTRODUCTION

  • Definition of microneedle

  • Scope of the report

  • Key features of the report

  • Objectives of the report

2. METHODOLOGY

  • Patent search, patent selection and patent analysis

  • Search strategy

  • Terminologies for patent analysis

  • Strength and blocking potential of patent portfolio

3. MAIN PATENT ASSIGNEES

4. EXECUTIVE SUMMARY

5. PATENT LANDSCAPE OVERVIEW

  • Time evolution of patent publications

  • Countries of patent filings

  • Time evolution by country

  • Main Patent Assignees

  • Main IP Players

  • Patent legal status

  • Mapping of main current IP holders

  • Patenting activity of IP leading companies

  • Time evolution of main patent assignees

  • IP Newcomers

  • Main IP collaborations

  • Main acquisitions

6. IP POSITION OF MAIN PATENT APPLICANTS

  • Beyond Quantity: Quantity Quality

  • IP leadership of patent assignees

  • Prior art blocking potential

  • Strength index

7. KEY PATENTS

  • Patent forward citation analysis

  • Key patent families

  • Main oppositions on EP patents

8. PATENT SEGMENTATION

  • Definition

  • Main assignees by application

  • Main assignees by type of microneedles

  • Main assignees by IP position and technology

  • Matrix applications vs technologies

9. IP PROFILE OF KEY PLAYERS

10. CONCLUSION

11. PUBLISHER PRESENTATION

Companies Mentioned

  • 3M

  • Altea

  • Becton Dickinson

  • Bioserentach

  • Boehringer Ingelheim

  • Clearside Biomedical

  • Corium

  • Cosmed Pharmaceutical

  • Fujifilm

  • Hisamitsu Pharmaceutical

  • Johnson & Johnson

  • Kimberly Clark

  • LG Household & Health Care

  • LTS Lohmann Therapy Systems

  • Nanomed

  • Nanopass Technology

  • Nissha

  • Nitto

  • Procter & Gamble

  • Raphas

  • Silicon Microdevices

  • Sorrento Therapeutics

  • Theraject

  • Toppan Printing

  • Vaxxas

  • Zealand Pharma

  • Zosano Pharma

For more information about this report visit https://www.researchandmarkets.com/r/uk0bvx

View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005433/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest stories